NCT04678388View on ClinicalTrials.gov

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

PHASE1UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

December 12, 2020

Study Completion Date

December 12, 2020

Conditions
Cardiovascular Diseases
Interventions
DRUG

Reference drug

1 Cap., single oral administration under fasting condition

DRUG

Test drug 1

1 Tab., single oral administration under fasting condition

DRUG

Test drug 2

1 Tab., single oral administration under fasting condition

Trial Locations (1)

15079

Central Hospital, Gyeonggi-do

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY